← Back to Clinical Trials
Recruiting NCT06934603

NCT06934603 Microplastic Exposure From Clear Aligner Wear (MPE)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06934603
Status Recruiting
Phase —
Sponsor University of North Carolina, Chapel Hill
Condition Microplastic Exposure
Study Type OBSERVATIONAL
Enrollment 150 participants
Start Date 2025-08-08
Primary Completion 2035-07-01

Eligibility & Interventions

Sex All sexes
Min Age 10 Years
Max Age 75 Years
Study Type OBSERVATIONAL
Interventions
Clear Aligner Treatment

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 150 participants in total. It began in 2025-08-08 with a primary completion date of 2035-07-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

An observational longitudinal study measuring microplastic exposure and physiologic uptake in orthodontic patients receiving clear aligner treatment.

Eligibility Criteria

Inclusion Criteria: * Individuals (all sexes, genders, races, and ethnicities) aged at least 10 years (in adult dentition) and at most 75 years * Receiving comprehensive, Phase II orthodontic treatment with clear aligner therapy * Stable physical health (ASA I or II), as determined by study coordinator or PI * Able to comprehend and follow requirements of study (including availability on scheduled visit dates) * Patient and parental consent (and assent for minors) for participation in the study Exclusion Criteria: * Receiving orthodontic treatment with fixed appliances * Receiving hybrid treatment with fixed appliances and aligners * Receiving Phase I orthodontic treatment with fixed appliances * Established history of severe xerostomia (dry mouth), severe periodontal disease with actively bleeding gums, significant oral abrasions/ulcers or growths, current alcohol abuse, and/or recreational drug abuse * Other severe acute or chronic medical or psychiatric condition or laboratory abnormality that may increase risk associated with participation * Drinking, eating, or brushing teeth within 1 hour of study visit * Removing aligners within 1 hour of study visit * Developmental or cognitive disability such that the patient cannot self-consent, comprehend, and follow the requirements of the study based on research site personnel's assessment

Contact & Investigator

Central Contact

Laura A Jacox, DMD, PhD, MS

✉ ljacox@live.unc.edu

📞 919-537-3424

Principal Investigator

Laura A Jacox, DMD, PhD, MS

PRINCIPAL INVESTIGATOR

University of North Carolina, Chapel Hill

Frequently Asked Questions

Who can join the NCT06934603 clinical trial?

This trial is open to participants of all sexes, aged 10 Years or older, up to 75 Years, studying Microplastic Exposure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06934603 currently recruiting?

Yes, NCT06934603 is actively recruiting participants. Contact the research team at ljacox@live.unc.edu for enrollment information.

Where is the NCT06934603 trial being conducted?

This trial is being conducted at Chapel Hill, United States.

Who is sponsoring the NCT06934603 clinical trial?

NCT06934603 is sponsored by University of North Carolina, Chapel Hill. The principal investigator is Laura A Jacox, DMD, PhD, MS at University of North Carolina, Chapel Hill. The trial plans to enroll 150 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology